MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner
Felix Y. Feng(University of Michigan), Daniel A. Hamstra, Connor Luczak(University of Michigan), Skyler B. Johnson(University of Michigan), Joseph R. Evans(University of Michigan), Will Jackson(University of Michigan), Shaomeng Wang(University of Michigan), Wei Chen(Gansu Agricultural University), Yu Zhang(Wannan Medical College), Vishal Kothari(University of Michigan)
Cited by 63
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694